4

OWNERSHIP DOCUMENT

Company: Hepion Pharmaceuticals, Inc.
Filed: December 8, 2020
Period of Report: December 8, 2020
Accession Number: 0001104659-20-133141

View Document ↗ View on SEC.gov ↗